Evolving Diagnostic Criteria for Arrhythmogenic Cardiomyopathy

Domenico Corrado1, Alessandro Zorzi1, Alberto Cipriani1

  • 1Department of Cardiac, Thoracic and Vascular Sciences and Public Health University of Padova Italy.

Insights

The 2020 International criteria for arrhythmogenic cardiomyopathy (ACM) enhance diagnosis by including left ventricular involvement and cardiac magnetic resonance imaging. These updated guidelines improve detection of the full spectrum of ACM phenotypes.

Area of Science:

  • Cardiology
  • Medical Diagnostics
  • Cardiac Imaging

Background:

  • Previous arrhythmogenic cardiomyopathy (ACM) diagnostic criteria (1994, 2010) accurately identified right ventricular disease but missed left-sided variants.
  • These earlier criteria did not incorporate cardiac magnetic resonance (CMR) late-gadolinium enhancement (LGE) findings, crucial for fibrosis detection.

Purpose of the Study:

  • To review the evolution of ACM diagnostic criteria.
  • To detail the advancements introduced by the 2020 International criteria (Padua criteria).
  • To highlight the improved diagnostic capabilities for the expanding ACM phenotypic spectrum.

Main Methods:

  • Review of historical (1994, 2010) and current (2020) International Task Force criteria for ACM diagnosis.
  • Emphasis on the role of cardiac magnetic resonance (CMR) with late-gadolinium enhancement (LGE) in the 2020 criteria.
  • Inclusion of new criteria for left ventricular (LV) abnormalities and arrhythmias.

Main Results:

  • The 2020 criteria significantly improve the diagnosis of arrhythmogenic biventricular and left ventricular cardiomyopathy.
  • CMR with LGE is now mandatory for characterizing ACM phenotypes and excluding other conditions.
  • New ECG and arrhythmia criteria enhance the identification of left-sided ACM variants.

Conclusions:

  • The 2020 International criteria represent a major advancement in diagnosing the full spectrum of arrhythmogenic cardiomyopathy.
  • Cardiac magnetic resonance imaging is indispensable for accurate ACM diagnosis under the new guidelines.
  • These criteria enhance the ability to detect and characterize both right and left ventricular involvement in ACM.

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
127
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
117
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
96
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
77
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
151
Dysrhythmias II: Classification of Tachyarrhythmias01:28

Dysrhythmias II: Classification of Tachyarrhythmias

Tachyarrhythmias are a type of dysrhythmia where the heart rate exceeds 100 beats per minute. Here are some common types of tachyarrhythmias:Sinus TachycardiaSinus tachycardia originates from increased impulses from the sinus node, leading to an elevated heart rate. It is often triggered by stress, fever, or exercise.Patients may experience palpitations, a sensation of a racing heart, dizziness, and chest discomfort.Causes and Risk Factors: Common causes include physical exertion, emotional...
198